Results 1 to 10 of about 168,078 (280)

Uptake of the hepatitis B vaccine among brothel-based female sex workers in Kampala, Uganda [PDF]

BMC Public Health
Background Hepatitis B is a significant health problem worldwide, particularly among high-risk groups such as female sex workers (FSWs). In Uganda, it is highly recommended that FSWs receive the hepatitis B vaccine.
Joana Nakiggala, Mathias Lwenge, Doreen Nakalembe, Bridget Nagawa Tamale, Aisha Nalugya, Jovan Galiwango, Junior Mike Wejuli, Kenneth Tebandeke, John Bosco Isunju, Richard K. Mugambe, Tonny Ssekamatte   +10 more
doaj   +2 more sources

Uptake of the Hepatitis B Vaccine Among Pre‐Service Health Professionals in Rwanda [PDF]

Public Health Challenges
Background High hepatitis B vaccine uptake has led to significant reductions in hepatitis B infection rates and associated health burdens in many countries.
Bivegete Kenny Ntwari, Felix K. Rubuga, Silene Jolie Uwingabiye, Vincent Dushimimana, Jean Baptiste Hategekimana, Serieux Cyubahiro, Ivan Steve Rwema, Daniel Ukwishatse, Patrick Karakwende, Jean Muhire, Adolphe Ndikubwimana, Theoneste Ntakirutimana, Pierre Dukuziyaturemye, Didas Mugisha, Canisius Gasana, Edith Musabwa, Felicien Irafasha, Celestin Banamwana, Frank Gasana, Idrissa Nkurunziza, Deborah Oluwaseun Shomuyiwa, Don Eliseo Lucero‐Prisno III   +21 more
doaj   +2 more sources

Hepatitis B Vaccine: Four Decades on [PDF]

Vaccines
Hepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC) globally. Vaccination is the most effective method for prevention of hepatitis B and its associated morbidity and mortality, and the only method to prevent ...
Maria Mironova, Marc G. Ghany
doaj   +2 more sources

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review [PDF]

Human Vaccines & Immunotherapeutics
Hepatitis B vaccination is the most effective means of interrupting HBV transmission. Although the hepatitis B vaccine is very effective and safe, adverse events following immunization do occur and need to be reported so that problems can be identified ...
Xiaoying Gong, Quanjun Fang, Jianyue Zhong, Canjie Zheng, Zhiying Yin   +4 more
doaj   +2 more sources

Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping Review [PDF]

Pathogens
Background: The advent of the hepatitis B vaccine has achieved tremendous success in eradicating and reducing the burden of hepatitis B infection, which is the main culprit for hepatocellular carcinoma—one of the most fatal malignancies globally ...
Nura Bello, Shuaibu A. Hudu, Ahmed S. Alshrari, Mustapha U. Imam, Abdulgafar O. Jimoh   +4 more
doaj   +2 more sources

Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study [PDF]

Journal of Tropical Medicine
Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality.
Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Sa’adatu Haruna Shinkafi, Albashir Tahir, Ahmed Subeh Alshrari, Muhammad Tukur Umar, Abdulmajeed Yunusa, Nura Bello, Nura Abubakar   +8 more
doaj   +2 more sources

Time interval distribution of hepatitis B vaccine immunization among infants in China from 2017 to 2021 [PDF]

Human Vaccines & Immunotherapeutics
Infant hepatitis B vaccine coverage in China is high, with over 95% of infants immunized; however, high vaccine coverage can often mask low timeliness.
Sihui Zhang, Xiaoling Tian, Li Wang, Ming Liu, Chao Wang, Tianshuo Zhao, Xianming Cai, Xiyu Zhang, Mingting Wang, Juan Du, Yaqiong Liu, Qingbin Lu, Jiang Wu, Ninghua Huang, Fuqiang Cui   +14 more
doaj   +2 more sources

Hepatitis B Vaccines [PDF]

The Journal of Infectious Diseases, 2021
Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn, Jade, Hendrickx, Greet, Vorsters, Alex, van Damme, Pierre   +3 more
openaire   +3 more sources

Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B

Vaccines, 2022
Nasvac (HeberNasvac®) is a novel therapeutic vaccine for chronic hepatitis B (CHB). This product is a formulation of the core (HBcAg) and surface (HBsAg) antigens of the hepatitis B virus (HBV), administered by nasal and subcutaneous routes, in a ...
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar   +2 more
doaj   +1 more source

Immunogenicity of two different dosages (10 and 5 μg) of recombinant DNA hepatitis B vaccine in healthy neonates [PDF]

, 1994
The immunogenicity of a half (5 μg) and a full (10 μg) dosage of recombinant DNA yeast-derived hepatitis B vaccine (HB-Vax-DNA) in healthy neonates was assessed in order to compare two candidate dosages of vaccine.
Del Cancho, R. (R.), Grosheie, P.M. (P.), Heijtink, R.A. (Rudolf), Huisman, W. (Willem), Schalm, S.W. (Solko), Voogd-Schotanus, M. (M.)   +5 more
core   +8 more sources